New York Life Investment Management’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-297,744
Closed -$18M 882
2024
Q3
$18M Sell
297,744
-159
-0.1% -$9.41K 0.18% 112
2024
Q2
$16.8M Buy
297,903
+120,502
+68% +$6.72M 0.17% 124
2024
Q1
$10M Buy
177,401
+131,900
+290% +$7.14M 0.1% 189
2023
Q4
$2.04M Sell
45,501
-1,958
-4% -$79.2K 0.02% 541
2023
Q3
$2.16M Buy
47,459
+10,824
+30% +$506K 0.02% 501
2023
Q2
$1.59M Buy
36,635
+7,941
+28% +$349K 0.02% 557
2023
Q1
$1.89M Buy
28,694
+594
+2% +$36.7K 0.02% 525
2022
Q4
$1.26M Buy
28,100
+29
+0.1% +$1.58K 0.01% 595
2022
Q3
$2.03M Sell
28,071
-39
-0.1% -$3.87K 0.02% 505
2022
Q2
$3.02M Buy
+28,110
New +$2.86M 0.04% 413

Other funds holding CTLT

New York Life Investment Management's CTLT Position: Q4 2024 in Review

New York Life Investment Management sold out of CATALENT, INC. (CTLT) in Q4 2024, closing a stake of 297,744 shares — an estimated $18M sold.

New York Life Investment Management first reported a position in CTLT in Q2 2022 and held it in 10 quarters. The position peaked at $18M in Q3 2024. 6 funds tracked by Wall St. Rank hold CTLT as of Q4 2024.

  • New York Life Investment Management reported no remaining CATALENT, INC. position as of Q4 2024 after selling out during the quarter.
  • New York Life Investment Management sold 297,744 CATALENT, INC. shares in Q4 2024, an estimated $18M.
  • New York Life Investment Management first reported a position in CATALENT, INC. in Q2 2022 and held it in 10 quarters.
  • New York Life Investment Management's CATALENT, INC. position peaked at $18M in Q3 2024.
  • 6 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2024.

Based on New York Life Investment Management's 13F filing for Q4 2024, filed 5 Feb 2025.